Rule 26 Compliance
In accordance with AIM Rule 26, as stipulated by the London Stock Exchange, all AIM-quoted companies are required to disclose certain information on their corporate website.
In compliance with this Rule, Syntopix (incorporated in England & Wales, main country of operation United Kingdom and Registered Company number 5656604) has provided the following information on this site:
- AIM admission document.
- Annual reports.
- Interim reports.
- Memorandum and Articles of Association.
- Business description.
- Details of nominated advisers/other key advisers.
- Directors' biographies.
- Statement of Director's responsibilities and committee membership details.
- Major shareholders.
- Notifications.
The percentage of shares not in public hands is 40.85%
The information above was updated on 22/10/2008.
For further information regarding Syntopix's AIM Rule 26 compliance please contact Dr. Stephen P. Jones - Chief Executive Officer, spj@syntopix.com.
Last updated: 22/10/2008
Recent News
23/08/2010 07:00
AGREEMENT WITH GLOBAL CONSUMER PRODUCTS COMPANY
Syntopix signs an exclusive agreement with a world leading health and personal care brands company.
22/06/2010 07:00
Syntopix welcomes a new board member with Mike Townend joining as Non-executive Director
22/04/2009 13:13
03/02/2010 07:00
Syntopix announces a Directorate change with Tom Bannatyne joining as Chairman.
12/11/2009 07:00
Syntopix announces positive results for its lead dermatological compound SYN0126
